Protein tyrosine phosphatases play a crucial role in proliferation, differentiation, and transformation of cells. Among them, two SH2 domain-containing enzymes, namely SHP-1 and SHP-2, have attracted the most attention in recent years. Both SHP-1 and SHP-2 are important signaling transducers and potential targets for therapeutic drugs to treat blood disorders, cancer, and heart disease. Much is also known about the regulation of the enzymes and the consequences of their deficiencies. These two enzymes share significant overall sequence identity and are regulated by recruitment to tyrosine-phosphorylated receptors through their SH2 domains. However, they display opposite as well as common functions. The mechanism underlying this is not fully understood, and their precise functions in many cellular progresses are poorly defined. In earlier studies, we identified two immunoglobulin family cell surface proteins, namely, LAIR-1 and PZR that contain immunoreceptor tyrosine-based inhibition motifs (ITIMs). Through ITIMs/SH2 interactions, LAIR-1 and PZR specifically recruit SHP-1 and SHP-2, respectively. We have now generated monoclonal antibodies against the extracellular part of LAIR-1 and PZR. These antibodies induce tyrosine phosphorylation of the proteins and thus respective recruitment of SHP-1 and SHP-2. We have also purified cell membrane-permeable proteins carrying tyrosine-phosphorylated ITIMs of LAIR-1 and PZR. When introduced into cells, these membrane permeable, tyrosine-phosphorylated proteins respectively bind SHP-1 and SHP-2 and block their translocation and thus function. Our central hypothesis is that LAIR-1 and PZR play a maj or role in defining specificity of SHP 1 and SHP-2 and by using monoclonal anti-LAIR-1 and anti-PZR antibodies and membrane-permeable, tyrosine-phosphorylated proteins derived from LAIR-1 and PZR we can specifically modulate the functions of SHP-1 and SHP-2. In this study, we will thoroughly investigate the effects of these reagents on the development of human CD34+ hematopoietic progenitor cells in vitro and in NOD-SCID mice and on the activation ofT lymphocytes in vitro. We will further determine the binding affinity of SH2 domains of SHP-1 and SHP-2 with ITIMs of inhibitory receptors, co-crystallize SHP-1 and SHP-2 with specific tandem ITIMs, and identify two proteins that are hyper-phosphorylated when the functions of SHP-1 and SHP-2 are blocked. This study will not only provides a better understanding of the specific function of SHP-1 and SHP-2 but also reveals the regulatory role of LAIR-1 and PZR. The reagents generated in this study should serve as valuable tools to study cellular processes involving SHP-1 and SHP-2 and to develop therapeutic

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL076309-02
Application #
6866601
Study Section
Biochemistry Study Section (BIO)
Program Officer
Thomas, John
Project Start
2004-04-01
Project End
2005-07-31
Budget Start
2005-04-01
Budget End
2005-07-31
Support Year
2
Fiscal Year
2005
Total Cost
$15,171
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Jin, Xi; Zhao, Wanke; Kirabo, Annet et al. (2014) Elevated levels of mast cells are involved in pruritus associated with polycythemia vera in JAK2V617F transgenic mice. J Immunol 193:477-84
Jin, Xi; Zhao, Wanke; Shi, Kaiyao et al. (2013) Generation of a new congenic mouse strain with enhanced chymase expression in mast cells. PLoS One 8:e84340
Yu, Xiaokun; Ma, Junfeng; Lin, Feng et al. (2012) Myotubularin family phosphatase ceMTM3 is required for muscle maintenance by preventing excessive autophagy in Caenorhabditis elegans. BMC Cell Biol 13:28
Ma, Junfeng; Li, Zhe; Xing, Shu et al. (2011) Tea contains potent inhibitors of tyrosine phosphatase PTP1B. Biochem Biophys Res Commun 407:98-102
Yuan, Taichang; Wang, Yongping; Zhao, Zhizhuang J et al. (2010) Protein-tyrosine phosphatase PTPN9 negatively regulates ErbB2 and epidermal growth factor receptor signaling in breast cancer cells. J Biol Chem 285:14861-70
Xing, Shu; Wanting, Tina Ho; Zhao, Wanming et al. (2008) Transgenic expression of JAK2V617F causes myeloproliferative disorders in mice. Blood 111:5109-17
Ma, Junfeng; Zeng, Fenghua; Ho, Wanting Tina et al. (2008) Characterization and functional studies of a FYVE domain-containing phosphatase in C. elegans. J Cell Biochem 104:1843-52
Li, Zhe; Xing, Shu; Wang, Shaofeng et al. (2007) Characterization of a highly effective protein substrate for analysis of JAK2(V617F) Activity. Exp Hematol 35:1624-32
Xu, Xuesong; Zhang, Qi; Luo, Jian et al. (2007) JAK2(V617F): Prevalence in a large Chinese hospital population. Blood 109:339-42
Li, Zhe; Xu, Mingjiang; Xing, Shu et al. (2007) Erlotinib effectively inhibits JAK2V617F activity and polycythemia vera cell growth. J Biol Chem 282:3428-32

Showing the most recent 10 out of 14 publications